REG - Indivior PLC - Transaction in Own Shares

IndiviorAnnouncement

07/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250107:nRSG2906Sa&default-theme=true

RNS Number : 2906S  Indivior PLC  07 January 2025

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

January 7, 2025

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 141,363 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from December 30, 2024, up to and
including January 3, 2025, in connection with its $100m Share Repurchase
Program. Aggregated information on the purchase of these shares can be found
in the table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 124,828,603 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (124,828,603) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 30/12/2024    LSE            40,945                                      975.63
 30/12/2024    BATE           2,428                                       969.81
 30/12/2024    CHIX           10,282                                      969.40
 30/12/2024    AQUIS          391                                         967.13
 31/12/2024    LSE            6,667                                       994.13
 31/12/2024    BATE           3,059                                       990.74
 31/12/2024    CHIX           2,324                                       992.82
 31/12/2024    AQUIS          263                                         989.57
 02/01/2025    LSE            36,112                                      1,017.21
 02/01/2025    BATE           508                                         1,021.00
 02/01/2025    CHIX           233                                         1,018.06
 03/01/2025    LSE            17,457                                      994.80
 03/01/2025    BATE           5,230                                       992.37
 03/01/2025    CHIX           12,303                                      993.13
 03/01/2025    AQUIS          3,161                                       984.03

 

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSGZGGMKVGGKZM